Trials / Conditions / Super-refractory Status Epilepticus
Super-refractory Status Epilepticus
4 registered clinical trials studyying Super-refractory Status Epilepticus — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | KD Treatment for Super-refractory Status Epilepticus NCT07496749 | Xuanwu Hospital, Beijing | N/A |
| Completed | A Study With SAGE-547 for Super-Refractory Status Epilepticus NCT02477618 | Supernus Pharmaceuticals, Inc. | Phase 3 |
| Completed | Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilep NCT02052739 | Supernus Pharmaceuticals, Inc. | Phase 1 / Phase 2 |
| No Longer Available | An Open Label, Expanded Access Protocol With SAGE-547 for Super-Refractory Status Epilepticus NCT02433314 | Supernus Pharmaceuticals, Inc. | — |